Treatment Outcomes in Patients With Newly Diagnosed Epilepsy Treated With Established and New Antiepileptic Drugs: A 30-Year Longitudinal Cohort Study

By Zhibin Chen, M. Brodie, D. Liew, Patrick Kwan. JAMA Neurology, 2017

1,313 citations recorded by the source corpus.

Subfields: Economics and Econometrics, Pediatrics, Perinatology and Child Health, Psychiatry and Mental health

View Paper: https://www.semanticscholar.org/paper/056f345090b700811290bde8e954a695948291d2

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Pediatrics, Perinatology and Child Health

1. Wolfgang Löscher
2. A. Vezzani
3. Heidrun Potschka

In Psychiatry and Mental health

1. A. Vezzani
2. Heidrun Potschka
3. Wolfgang Löscher

Citations in the corpus

• Drug Resistance in Epilepsy: Clinical Impact, Potential Mechanisms, and New Innovative Treatment Options (2020, background): “A single-center 30-year longitudinal cohort study found a similar proportion of people not seizure-free at terminal outcome, identifying as risk factors for this outcome the number of seizures occurring in the year before treatment began, previous recreational drug use, and a family history of epile”